These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15250325)

  • 1. [Dialysis encephalopathy].
    Kinugasa E; Yamamoto M; Fukui T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():361-5. PubMed ID: 15250325
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aluminum and iron deposition in dialysis patients].
    Kashiwagi T; Kurihara S
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():400-5. PubMed ID: 15250334
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dialysis encephalopathy, dialysis dementia].
    Kinugasa E; Ideura T; Akizawa T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):139-42. PubMed ID: 11031916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uremic encephalopathy, dialysis encephalopathy].
    Kinugasa E
    Nihon Rinsho; 2004 Jan; 62 Suppl():424-8. PubMed ID: 15011399
    [No Abstract]   [Full Text] [Related]  

  • 5. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aluminium].
    Nomoto S; Honda T; Nakabayashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():326-8. PubMed ID: 15658330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ; Sharf B; Bell P; Meyers AM
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine and aluminum removal.
    Swartz RD
    Am J Kidney Dis; 1985 Nov; 6(5):358-64. PubMed ID: 3904429
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dialysis encephalopathy].
    Ogura Y; Yokoyama K; Ohara M
    Nihon Rinsho; 1992 Jan; 50 Suppl():836-41. PubMed ID: 1578775
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum and iron overload in chronic dialysis.
    Ackrill P; Day JP; Ahmed R
    Kidney Int Suppl; 1988 Mar; 24():S163-7. PubMed ID: 3283407
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acquired idiopathic sideroblastic anemia].
    Kitajima H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():328-31. PubMed ID: 12013878
    [No Abstract]   [Full Text] [Related]  

  • 15. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis dementia.
    Mach JR; Korchik WP; Mahowald MW
    Clin Geriatr Med; 1988 Nov; 4(4):853-67. PubMed ID: 3066464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminium overload influences cognitive function in patients on dialysis.
    Kambova L; Ionova D; Kirijakov Z
    Nephrol Dial Transplant; 1994; 9(9):1357. PubMed ID: 7816312
    [No Abstract]   [Full Text] [Related]  

  • 18. Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
    Marumo F; Umetani N; Sato N; Takahashi Y
    J UOEH; 1987 Mar; 9 Suppl():140-52. PubMed ID: 3602745
    [No Abstract]   [Full Text] [Related]  

  • 19. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered biodistribution of gallium-67 in a patient with aluminum toxicity treated with desferoxamine.
    Brown SJ; Slizofski WJ; Dadparvar S
    J Nucl Med; 1990 Jan; 31(1):115-7. PubMed ID: 2295931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.